(Sharecast News) - Abingdon Health announced a strategic partnership with Okos Diagnostics on Monday to co-develop, manufacture and commercialise lateral flow test kits for avian influenza (H5N1), targeting both bovine and human health applications.
The AIM-traded firm said the agreement would see the two firms collaborate to adapt Okos' existing prototype...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE